Standout Papers

Ranibizumab for Neovascular Age-Related Macular Degeneration 2006 2026 2012 2019 4.5k
  1. Ranibizumab for Neovascular Age-Related Macular Degeneration (2006)
    Philip J. Rosenfeld, David M. Brown et al. New England Journal of Medicine
  2. Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration (2006)
    David M. Brown, Peter K. Kaiser et al. New England Journal of Medicine
  3. Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration (2012)
    Jeffrey S. Heier, David M. Brown et al. Ophthalmology
  4. Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study (2008)
    David M. Brown, Mark Michels et al. Ophthalmology
  5. The International Vitreomacular Traction Study Group Classification of Vitreomacular Adhesion, Traction, and Macular Hole (2013)
    Jay S. Duker, Peter K. Kaiser et al. Ophthalmology
  6. Estimation of rock mass deformation modulus and strength of jointed hard rock masses using the GSI system (2003)
    Ming Cai, Peter K. Kaiser et al. International Journal of Rock Mechanics and Mining Sciences
  7. Modelling brittle failure of rock (2002)
    Peter K. Kaiser, C. Derek Martin et al. International Journal of Rock Mechanics and Mining Sciences
  8. Design of rock support system under rockburst condition (2012)
    Peter K. Kaiser, Ming Cai Journal of Rock Mechanics and Geotechnical Engineering
  9. Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab (2020)
    Jordi Monés, Sunil Srivastava et al. Ophthalmology

Immediate Impact

18 by Nobel laureates 15 from Science/Nature 115 standout
Sub-graph 1 of 21

Citing Papers

Age-Related Macular Degeneration
2024 Standout
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
2024 Standout
29 intermediate papers

Works of Peter K. Kaiser being referenced

Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
2006 Standout
and 10 more

Author Peers

Author Last Decade Papers Cites
Peter K. Kaiser 17980 13564 3750 425 25.8k
Max A. Viergever 1682 15990 782 524 31.3k
Y. C. Fung 242 2018 1083 223 27.0k
Hiroshi Ishikawa 6791 5520 1562 904 22.2k
Jianping Zuo 337 225 4245 504 15.6k
Ken Hayashi 4923 4095 458 395 8.1k
Joachim Hornegger 3232 6383 332 347 11.3k
Ruikang K. Wang 9013 10661 2055 878 22.4k
J. Stuart Nelson 1695 6169 1075 560 22.0k
Haoyu Chen 2186 1695 1820 333 6.4k
Alejandro F. Frangi 385 3952 456 472 14.6k

All Works

Loading papers...

Rankless by CCL
2026